Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors. Almario CV, Chey WD, Spiegel BMR. Am J Gastroenterol 2020;115:1922-1923.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Almario CV, Chey WD, Spiegel BMR. Response to Hajifathalian and Katz Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors. Am J Gastroenterol 2020;115:1922-1923.
PMID: 33156118